Cerebrolysin is a porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids. It mimics endogenous neurotrophic factors (BDNF, NGF, GDNF, CNTF) and is widely studied for neuroprotection, synaptic plasticity and post-stroke recovery research.

📊Clinical Studies & Results

Cerebrolysin has been investigated in multiple RCTs for acute ischemic stroke and vascular cognitive impairment.

▪CASTA trial: improved neurological recovery at 90 days
▪CARS-1: enhanced motor function after stroke
▪Meta-analyses show benefit in vascular dementia

Cerebrolysin remains a well-studied neurotrophic peptide preparation with extensive preclinical and clinical evidence.

🏆Benefits

Supports synaptic plasticity and neurogenesis
Neuroprotective effects in ischemic stroke models
Modulates amyloid-β processing in research models
Improves cognitive performance markers

⚠️Possible Side Effects

▪Mild transient injection-site reaction
▪Rare hypersensitivity reactions
▪Transient agitation reported
▪Avoid in epilepsy research subjects

🎯Ideal For

→Neurodegeneration research
→Stroke recovery models
→Vascular dementia studies
→Traumatic brain injury models

LABORATORY REAGENT – FOR RESEARCH PURPOSES ONLY

This product is not a drug or food and should be handled by qualified professionals in laboratory conditions. All product information is provided for educational purposes only.

Description

Information:

The product (substance) isn't a food or diet supplement and is not suitable for human consumption.
Keep out of children's reach
Keep container tightly closed.
Store in a dry, cool and shaded place; protect from moisture.
Store only in the original container.
Avoid contact during pregnancy and breast feeding.
Consult a doctor in the event of feeling unwell or having adverse effects related to the contact with the substance.